What is the Ownership and Shareholding Structure of Leucine Medtech?
In 2023, Leucine Medtech had a promoter holding of 92.44% and a public holding of 7.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.











Company Details
+91-XXXXXXXXXX